Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M39.9Revenue (TTM) $M0.1Net Margin (%)-53,705.0Altman Z-Score-7.9
Enterprise Value $M-4.6EPS (TTM) $-0.9Operating Margin %-59,693.0Piotroski F-Score3
P/E(ttm)--Beneish M-Score-4.5Pre-tax Margin (%)-53,704.0Higher ROA y-yN
Price/Book1.210-y EBITDA Growth Rate %-7.8Quick Ratio3.9Cash flow > EarningsY
Price/Sales3005-y EBITDA Growth Rate %-3.0Current Ratio3.9Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-75.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-114.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M66.8ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with CYTR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CYTRGeorge Soros 2014-06-30 Sold Out $2.92 - $5.31
($3.79)
$ 0.60-84%Sold Out0
CYTRGeorge Soros 2014-03-31 Buy $3.18 - $8.08
($5.96)
$ 0.60-90%New holding81,800
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CYTR is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CYTR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Patterson Scott Bradford10% Owner 2013-12-03Buy284,979$2.44-75.41view
Patterson Scott Bradford10% Owner 2013-11-07Buy50,000$2.06-70.87view
Patterson Scott Bradford10% Owner 2013-04-01Buy4,083$2.7-77.78view
Patterson Scott Bradford10% Owner 2013-03-20Buy35,520$2.58-76.74view
Patterson Scott Bradford10% Owner 2013-03-20Buy3,980$2.61-77.01view
Patterson Scott Bradford10% Owner 2013-03-13Buy55,360$2.67-77.53view
Patterson Scott Bradford10% Owner 2012-10-22Buy180,000$2.51-76.1view
Patterson Scott Bradford10% Owner 2012-10-18Buy1,200,000$2.5-76view
Patterson Scott Bradford10% Owner 2012-06-28Buy44,824$5.14-88.33view
Patterson Scott Bradford10% Owner 2012-06-25Buy27,462$5-88view

Quarterly/Annual Reports about CYTR:

News about CYTR:

Articles On GuruFocus.com
Weekly CFO Buys Highlight: CYTR, API, CLGX, PLBC, ARTC Mar 05 2012 
Weekly CEO Buys Highlight: ULBI, BDE, ALNY, CTTR, GFN Feb 27 2012 
Weekly CFO Buys Highlight: CYTR, PZZI, AGYS, PLBC Feb 27 2012 
CytRx Corp. Reports Operating Results (10-K) Mar 11 2011 
CytRx Corp. Reports Operating Results (10-Q) Nov 08 2010 
CytRx Corp. Reports Operating Results (10-Q) Aug 09 2010 
CytRx Corp. Reports Operating Results (10-Q) May 06 2010 
CytRx Corp. Reports Operating Results (10-Q) Nov 09 2009 
CytRx Corp. Reports Operating Results (10-Q) Aug 07 2009 

More From Other Websites
SHAREHOLDER ALERT: Goldberg Law PC Announces An Investigation of Claims Against CytRx Corporation... Jul 20 2016
Glancy Prongay & Murray Commences Investigation on Behalf of CytRx Corporation Investors Jul 20 2016
CytRx (CYTR) Is in Oversold Territory: What's Next? Jul 20 2016
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Violations... Jul 18 2016
10 Battered Biotech Stocks That Hit 52-Week Lows Friday Jul 18 2016
4 Companies That Destroyed Shareholders Last Week Jul 17 2016
CYTRX CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events Jul 15 2016
CytRx Corporation Announces Pricing of $20 Million Public Offering of Common Stock and Warrants Jul 15 2016
CytRx Corporation Announces Pricing of $20 Million Public Offering of Common Stock and Warrants Jul 15 2016
SHAREHOLDER NOTICE: Khang & Khang LLP Announces an Investigation of CytRx Corporation and Reminds... Jul 14 2016
CytRx Corporation Announces Proposed Public Offering of Common Stock and Warrants Jul 14 2016
CytRx Corporation Announces Proposed Public Offering of Common Stock and Warrants Jul 14 2016
INVESTOR ALERT: Investigation of CytRx Corporation Announced by Law Offices of Howard G. Smith Jul 14 2016
CYTRX CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to... Jul 14 2016
The Zacks Analyst Blog Highlights: Juno, Amgen, AbbVie, Gilead and CytRx Jul 14 2016
New Strong Buy Stocks for July 14th Jul 14 2016
What’s Next For CytRx Corporation (CYTR) Holders? Jul 13 2016
CytRx (CYTR) Stock Falls on Unfavorable Aldoxorubicin Data Jul 13 2016
After-hours buzz: JUNO, TEVA, SAGE & more Jul 12 2016
CytRx plunges after cancer study trial results disappoint Jul 12 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)